Famotidine-0.9% Nacl (famotidine in 0.9 % sodium chloride)
Last reviewed · Source: First Databank (FDB) drug data
Overview
USES: Famotidine is used to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. This medication is also used to treat certain stomach and throat (esophagus) problems (such as erosive esophagitis, gastroesophageal reflux disease-GERD, Zollinger-Ellison syndrome). It works by decreasing the amount of acid your stomach makes.
It relieves symptoms such as cough that doesn't go away, stomach pain, heartburn, and difficulty swallowing. Famotidine belongs to a class of drugs known as H2 blockers. This form of famotidine is given by vein and is used to treat these conditions for a short time when you cannot take the medication by mouth.
Your doctor should switch you to taking this medication by mouth when possible.
Generic name: famotidine in 0.9 % sodium chloride
Pronunciation: (fam-OH-tih-dine)
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Famotidine-0.9% Nacl
Indications
The following indications are listed for Famotidine-0.9% Nacl:
- Duodenal Ulcer
- Dyspepsia
- Dyspepsia Prevention
- Erosive Esophagitis
- Gastric Hypersecretion With Systemic Mastocytosis
- Gastric Ulcer
- Gastroesophageal Reflux Disease
- Heartburn
- Heartburn Prevention
- Maintenance Of Healing Duodenal Ulcer
- Multiple Endocrine Neoplasia
- Pathological Gastric Acid Hypersecretory Condition
- Reflux Esophagitis
- Zollinger-Ellison Syndrome
Also known as: Adenomatosis Partial Multiple Endocrine, Brash, Brash Prophylaxis, Dyspepsia Prophylaxis, Functional Dyspepsia, Functional Dyspepsia Prophylaxis, Gastric Acid Hypersecretory Conditions Due To Disease, Gastro-Esophageal Reflux, Gastro-Esophageal Reflux Disease With Esophagitis, Ge Reflux Disease, Heartburn Prophylaxis, Maintenance Of Healing Du, Multiple Endocrine Adenoma, Pancreatic Ulcerogenic Tumor Syndrome, Pathological Gastric Acid Hypersecretory States, Pathological Hypersecretion State, Pathological Hypersecretory Condition, Pyrosis, Pyrosis Prophylaxis, Systemic Mast Cell Disease With Gastric Hypersecretion, Z-E Syndrome.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.